Additional Study Medication


Indications and Reactions:

Role Indications Reactions
Secondary
Colon Cancer Metastatic 48.3%
Colorectal Cancer Metastatic 24.9%
Premedication 6.2%
Hypertension 5.8%
Prophylaxis 2.0%
Colon Cancer 1.7%
Colorectal Cancer 1.6%
Pain 1.5%
Prophylaxis Against Diarrhoea 1.2%
Sleep Disorder 1.2%
Wound Dehiscence 1.2%
Colorectal Cancer Stage Iv 0.7%
Thrombosis Prophylaxis 0.6%
Vomiting 0.6%
Vitamin Supplementation 0.6%
Peritoneal Carcinoma 0.5%
Hyperlipidaemia 0.4%
Ischaemic Heart Disease Prophylaxis 0.4%
Benign Prostatic Hyperplasia 0.3%
Breast Cancer 0.3%
Renal Failure Acute 59.5%
Wound Dehiscence 16.0%
Device Breakage 5.2%
Medical Device Complication 5.2%
Skin Ulcer 2.2%
Acute Coronary Syndrome 1.5%
Mucosal Inflammation 1.5%
Cellulitis 1.1%
Disease Progression 1.1%
Ascites 0.7%
Chest Pain 0.7%
Colitis 0.7%
Hyperglycaemia 0.7%
Pulmonary Embolism 0.7%
Transaminases Increased 0.7%
Vomiting 0.7%
Bile Duct Stone 0.4%
Cytotoxic Oedema 0.4%
Fatigue 0.4%
Headache 0.4%
Concomitant
Atrial Fibrillation 100.0%
Unevaluable Event 100.0%

Drug Data